Mettler-Toledo International Inc. (NYSE:MTD ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Adam Uhlman - Head of Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Dan Arias - Stifel Dan Leonard - UBS Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Josh Waldman - Cleveland Research Patrick Donnelly - Citi Tycho Peterson - Jefferies Michael Ryskin - Bank of America Operator Hello and welcome to the Mettler-Toledo Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.
Mettler-Toledo (MTD) came out with quarterly earnings of $10.21 per share, beating the Zacks Consensus Estimate of $10 per share. This compares to earnings of $9.80 per share a year ago.
Medical equipment maker Mettler-Toledo International beat third-quarter profit estimates on Thursday, helped by increased demand for its laboratory instruments used in drug development and research.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 1% compared with the prior year. Net earnings per diluted share as reported (EPS) were $9.96, compared with $9.21 in the prior-year period. Adjusted EPS was $10.21, an increase of 4% over the prior-year amount of $9.80. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is includ.
Get a deeper insight into the potential performance of Mettler-Toledo (MTD) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the UBS Global Healthcare Conference on Wednesday, November 13 at 11 a.m. EST, and the Stifel Healthcare Conference on Tuesday, November 19 at 1:15 p.m. EST. The Company will also present at the 7th Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 9:10 a.m. EST. A live webcast of the presentations will be available on the Company's investor relations website at.
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its third quarter 2024 financial results after the market close on Thursday, November 7, 2024. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MTD is a leading global supplier of precision instruments with a diversified product portfolio and geographic distribution. The company's operating model and buyback program position it for sustainable growth alongside free cash flows. Despite regional headwinds, MTD presents compelling value and is trading beneath its intrinsic business worth in my opinion.
Examine the evolution of Mettler-Toledo's (MTD) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.